Search

everythinglearnresearchcommunity

for

Search:↓

The document concludes that managing hirsutism involves identifying the cause, using a scoring system for severity, combining cosmetic and medical treatments, encouraging weight loss, and providing psychological support, while noting the need for more research on drug treatments.

Caucasian and Asian women with PCOS generally show similar symptoms, except Asian women have less chest hair.

Obesity worsens Polycystic Ovary Syndrome symptoms, and weight loss is a key treatment.

Teens with PCOS and a mom with PCOS have higher insulin resistance and lower adiponectin levels, which could signal early metabolic problems.

Diagnosing PCOS in teenagers should focus on signs of excess male hormones and not rely solely on ovarian ultrasound or irregular periods, and should be reassessed in adulthood.

PCOS may start before birth, involves metabolic issues, and can be treated with drugs like metformin and lifestyle changes.

The combination therapy improved PCOS symptoms in both obese and non-obese women, with weight loss in the obese group.

The document suggests a new model for evaluating public research that better captures the full value of knowledge creation and use, using PCOS research as an example.

Newer low-dose oral contraceptives with less androgenic effects improve patient compliance.

Managing PCOS is hard because it varies a lot, treatments are limited, and there's a lot of false information online.

Women with polycystic ovarian syndrome are more likely to have cervical insufficiency, especially South Asian and Black women.

Lower lipin 1β in belly fat is linked to insulin resistance in people with polycystic ovary syndrome.

The study found three different timing patterns of symptoms in women with premenstrual dysphoric disorder.

Isotretinoin improves severe acne without changing androgen or insulin levels but may increase body weight and triglycerides.

Androgen excess disorders in women were effectively treated with spironolactone, estrogen, and dexamethasone.

The document concludes that PCOS has a strong genetic component, but more research is needed to fully understand the specific genes involved.

Treating hirsutism in women often requires a mix of medications and cosmetic methods for best results.

Flightless I protein affects hair growth, with low levels delaying it and high levels increasing hair length in rodents.

Taking metformin with intense-pulsed-light therapy improves hair removal for people with PCOS.

The new FDA labeling rules provide more detailed drug safety information for pregnant and breastfeeding women, but more data is needed on the risks of many dermatologic drugs.

Different diagnostic criteria greatly affect PCOS diagnosis rates in teenagers.

The estradiol valerate/dienogest oral contraceptive helps with heavy periods, may improve acne and symptoms in PCOS, and doesn't affect sexual function.

Older obese women with PCOS have higher cardiovascular and metabolic risks despite lower androgen levels.

Timing of light therapy affects horse coat growth, with photoperiod being crucial.

Women with polycystic ovary syndrome have a higher risk of certain fractures.

Women with congenital adrenal hyperplasia have lower fertility, but with proper treatment, they can conceive successfully.

New treatments for excessive hair growth in women include insulin modulators and enzyme inhibitors.

High levels of male hormones in women without tumors are linked to metabolic problems and can be treated with metformin.

AMH is a good marker for diagnosing PCOS, but global standards are needed.

Testosterone therapy can modestly improve sexual function in menopausal women but should be used cautiously and is not recommended for routine measurement in sexual dysfunction or hirsutism.